Abstract
Current drug therapy strategies for the nervous system are based on the assumption that the adult central nervous system (CNS) lacks the capacity to make new nerve cells and regenerate after injury. Contrary to a long-held dogma, adult neurogenesis occurs in the adult brain and neural stem cells (NSCs) reside in the adult CNS. Neurogenesis in the adult brain is modulated in a broad range of environmental conditions, and physio- and pathological processes, as well as by trophic factors and drugs. This suggests that newborn neuronal cells of the adult brain may be involved in the functioning of the nervous system and may mediate a broad range of physio- and pathological processes, as well as the activities endogenous and exogenous factors and molecules. Hence, the confirmation that adult neurogenesis occurs in the adult brain and NSCs reside in the adult CNS force us to rethink how drugs are functioning and whether their activity may be mediated through adult neurogenesis. This will lead to the development and design of new strategies to treat neurological diseases and injuries, particularly drug therapy.
Keywords: Antidepressants, bromodeoxyuridine, neural stem cells, neurological diseases, pharmacology, trophic factors
Central Nervous System Agents in Medicinal Chemistry
Title: Adult Neurogenesis and Drug Therapy
Volume: 8 Issue: 3
Author(s): P. Taupin
Affiliation:
Keywords: Antidepressants, bromodeoxyuridine, neural stem cells, neurological diseases, pharmacology, trophic factors
Abstract: Current drug therapy strategies for the nervous system are based on the assumption that the adult central nervous system (CNS) lacks the capacity to make new nerve cells and regenerate after injury. Contrary to a long-held dogma, adult neurogenesis occurs in the adult brain and neural stem cells (NSCs) reside in the adult CNS. Neurogenesis in the adult brain is modulated in a broad range of environmental conditions, and physio- and pathological processes, as well as by trophic factors and drugs. This suggests that newborn neuronal cells of the adult brain may be involved in the functioning of the nervous system and may mediate a broad range of physio- and pathological processes, as well as the activities endogenous and exogenous factors and molecules. Hence, the confirmation that adult neurogenesis occurs in the adult brain and NSCs reside in the adult CNS force us to rethink how drugs are functioning and whether their activity may be mediated through adult neurogenesis. This will lead to the development and design of new strategies to treat neurological diseases and injuries, particularly drug therapy.
Export Options
About this article
Cite this article as:
Taupin P., Adult Neurogenesis and Drug Therapy, Central Nervous System Agents in Medicinal Chemistry 2008; 8 (3) . https://dx.doi.org/10.2174/187152408785699596
DOI https://dx.doi.org/10.2174/187152408785699596 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>Thespesia populnea</i>: An Ethnomedicinal, Phytochemical and Pharmacological
Review
The Natural Products Journal Mesenchymal Stem Cells Targeting of Systemic Disorders in Age-related Macular Degeneration
Current Tissue Engineering (Discontinued) Viruses and Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets The Endocannabinoid System and Pain
CNS & Neurological Disorders - Drug Targets Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Current Neuropharmacology DNA Secondary Structure at Chromosomal Fragile Sites in Human Disease
Current Genomics A Review Focused on Molecular Mechanisms of Anxiolytic Effect of <i>Valerina officinalis</i> L. in Connection with Its Phytochemistry through <i>in vitro/in vivo</i> Studies
Current Pharmaceutical Design The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development
CNS & Neurological Disorders - Drug Targets Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?
Current Neuropharmacology Update Clinical Application of Diffusion Tensor Imaging
Current Medical Imaging Synthetic and Natural Protease Inhibitors Provide Insights into Parasite Development, Virulence and Pathogenesis
Current Medicinal Chemistry Adult Neurogenesis in Epileptogenesis: An Update for Preclinical Finding and Potential Clinical Translation
Current Neuropharmacology HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects
Current Pharmaceutical Design Targeting γ-Aminobutyric Acid (GABA) Carriers to the Brain: Potential Relevance as Antiepileptic Pro-Drugs
Medicinal Chemistry Imaging of Muscarinic Receptors in the Central Nervous System
Current Pharmaceutical Design Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms
Current Medicinal Chemistry Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
Current Neuropharmacology Structural Bioinformatics in Broad-Spectrum Racemases: A New Path in Antimicrobial Research
Current Organic Chemistry Autonomic Nervous System Alterations in Rett Syndrome
Current Pediatric Reviews A Scientometrics Analysis and Visualization of Depressive Disorder
Current Neuropharmacology